Clinical utility of circulating tumor DNA in patients with advanced KRAS G12C-mutated NSCLC treated with sotorasib

被引:0
|
作者
Ernst, Sophie M.
van Marion, Ronald
Atmodimedjo, Peggy N.
de Jonge, Evert
Mathijssen, Ron H.
Paats, Marthe S.
de Bruijn, Peter
van Schaik, Ron H. N.
Dubbink, Hendrikus J.
Dingemans, Anne-Marie C.
机构
关键词
D O I
10.1158/1538-7445.AM2023-2137
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2137
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Sotorasib in combination with panitumumab in refractory KRAS G12C-mutated colorectal cancer: Safety and efficacy for phase Ib full expansion cohort
    Kuboki, Y.
    Yaeger, R.
    Fakih, M. G.
    Strickler, J. H.
    Masuishi, T.
    Kim, E. J.
    Bestvina, C. M.
    Langer, C. J.
    Krauss, J. C.
    Puri, S.
    Cardona, P.
    Chan, E.
    Tran, Q.
    Hong, D. S.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S680 - S681
  • [42] Sotorasib in KRAS p.G12C mutated advanced NSCLC: Real-word data from the Italian Expanded Access Program
    Reale, M. L.
    Passiglia, F.
    Brambilla, M.
    Pasello, G.
    Minuti, G.
    Bulotta, A.
    Pizzutilo, P.
    Sini, C.
    Costa, J.
    Roca, E.
    Bria, E.
    Pilotto, S.
    Genova, C.
    Metro, G.
    Citarella, F.
    Bordi, P.
    Russo, A.
    Chiari, R.
    Andrikou, K.
    Novello, S.
    ANNALS OF ONCOLOGY, 2023, 34
  • [43] MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) IN PREVIOUSLY TREATED KRAS G12C-MUTATED ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER (A/MNSCLC): ADAGRASIB VERSUS SOTORASIB
    Bouwmeester, W.
    Laurie, M.
    Korytowsky, B.
    Grevinga, M.
    Qian, C.
    Berardi, A.
    Gao, S.
    Stenehjem, D.
    VALUE IN HEALTH, 2023, 26 (12) : S31 - S31
  • [44] A Case Series of Patients With Kras KRAS G12C Mutation Treated With Sotorasib - Croatian Experience
    Seiwerth, F.
    Bitar, L.
    Franolic, I. Lukic
    Sajnic, A.
    Jakopovic, M.
    Samarzija, M.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S426 - S426
  • [45] Clinical validation of plasma cell-free DNA (cfDNA) sequencing in the phase 2 trial of sotorasib in patients (pts) with KRAS p.G12C mutated NSCLC.
    Bauml, Joshua M.
    Li, Bob T.
    Velcheti, Vamsidhar
    Govindan, Ramaswamy
    Fontecedro, Alessandra Curioni
    Dooms, Christophe
    Takahashi, Toshiaki
    Duda, Andrew W.
    Odegaard, Justin
    Cruz-Guilloty, Fernando
    Jin, Liming
    Zhang, Ying
    Skoulidis, Ferdinandos
    CANCER RESEARCH, 2021, 81 (13)
  • [46] Sotorasib in Advanced KRAS p.G12C-Mutated NSCLC with Treated or Untreated Brain Metastases: Safety and Efficacy Data from the Global Expanded Access Program (EAP)
    Awad, M. M.
    Pelizzari, G.
    Stevenson, J.
    Majem, M.
    Ferreira, C. Gil
    Petty, W.
    Arriola, E.
    De Castro, J.
    Morbeck, I.
    Bauman, J.
    Toschi, L.
    Zer, A.
    Metro, G.
    Kalmadi, S.
    Azkarate, A.
    Xia, C.
    Meloni, A.
    Obiozor, C.
    Hsu, H.
    Varrieur, T.
    Ardito-Abraham, C.
    Maimon, N.
    Novello, S.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : E17 - E17
  • [47] Sotorasib versus pembrolizumab in combination with platinum doublet chemotherapy as first-line treatment for metastatic or locally advanced, PD-L1 negative, KRAS G12C-mutated NSCLC (CodeBreaK 202)
    Barlesi, Fabrice
    Felip, Enriqueta
    Popat, Sanjay
    Solomon, Benjamin J.
    Wolf, Juergen
    Li, Bob T.
    Wu, Yi-Long
    Kerr, Keith
    Akamatsu, Hiroaki
    Camidge, David Ross
    Gupta, Ravi G.
    Meloni, Alison
    Dai, Tian
    Borghaei, Hossein
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [48] Rapid Response to Sotorasib of a Patient With KRAS G12C-Mutated Lung Cancer With Cancer-Associated Disseminated Intravascular Coagulation: A Case Report
    Kunimasa, Kei
    Tamiya, Motohiro
    Inoue, Takako
    Kawamura, Takahisa
    Nishino, Kazumi
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (01):
  • [49] Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
    Fakih, Marwan G.
    Salvatore, Lisa
    Esaki, Taito
    Modest, Dominik P.
    Lopez-Bravo, David P.
    Taieb, Julien
    Karamouzis, Michalis V.
    Ruiz-Garcia, Erika
    Kim, Tae-Won
    Kuboki, Yasutoshi
    Meriggi, Fausto
    Cunningham, David
    Yeh, Kun-Huei
    Chan, Emily
    Chao, Joseph
    Saportas, Yaneth
    Tran, Qui
    Cremolini, Chiara
    Pietrantonio, Filippo
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (23): : 2125 - 2139
  • [50] Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation
    Waterhouse, David M.
    Rothschild, Sacha
    Dooms, Christophe
    Mennecier, Bertrand
    Bozorgmehr, Farastuk
    Majem, Margarita
    Heuvel, Michel H. van den
    Linardou, Helena
    Cho, Byoung Chul
    Roberts-Thomson, Rachel
    Tanaka, Kentaro
    Blais, Normand
    Schvartsman, Gustavo
    Hansen, Karin Holmskov
    Chmielewska, Izabela
    Forster, Martin D.
    Giannopoulou, Christina
    Stollenwerk, Bjorn
    Obiozor, Cynthia C.
    Wang, Yang
    Novello, Silvia
    LUNG CANCER, 2024, 196